Velano Vascular announced this month that it closed the second tranche of a $25 million growth financing to bring its total funding to more than $50 million.
San Francisco-based Velano develops vascular access technologies designed to enable blood draws from indwelling peripheral IV catheters. The company’s blood collection practice is designed to reduce reliance on repeat needle sticks and central line access for blood draws.